M. W. Ahmud, M. Mustafa, and W. Asim, “A rare disease gets a breakthrough: Ctexli approved for cerebrotendinous xanthomatosis”, Int J Basic Clin Pharmacol, vol. 14, no. 4, pp. 649–650, Jun. 2025.